Skip to main content
. 2021 May 17;11:603271. doi: 10.3389/fonc.2021.603271

Table 3.

The characteristics of 43 patients for clinical validation.

Total Up (n, %) Down (n, %) p
Age (years)
<60 11 5 (27.8) 6 (24.0) 0.779
≥60 32 13 (72.2) 19 (76.0)
Gender
Male 34 14 (77.8) 20 (80.0) 0.86
Female 9 4 (22.2) 5 (20.0)
Smoking status
Yes 29 13 (72.2) 12 (48.0) 0.57
No 14 5 (27.8) 13 (52.0)
Stage
I 12 6 (33.3) 6 (24.0) 0.763
II 25 10 (55.6) 15 (60.0)
III 6 2 (11.1) 4 (16.0)
Treatment
S+C/R 17 5 (27.8) 12 (48.0) 0.181
C+R 26 13 (72.2) 13 (52.0)